N/A
N=1,005
Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial
High-risk Medications
Bottom Line
View on ClinicalTrials.gov: NCT02785458 ↗Enrolled (actual)
1,005
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcome: Primary: Medication Knowledge (0-100) — 71.2; 71.9; 73.2; 74.9 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- EMC2 Strategy (Behavioral)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- Northwestern University
- Primary completion
- Sep 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Medication Knowledge (0-100) |
71.2; 71.9; 73.2; 74.9; 73.2; 75.0 | — |
| SECONDARY Probability of Prescription Medication Proper Use |
0.84; 0.81; 0.83; 0.80 | — |
Summary
This study evaluates the effectiveness of an electronic health record based educational intervention (the EMC2 strategy) to improve patient understanding and use of higher-risk medications. Half of the participants will receive the intervention, while the other half will receive the usual amount of information (usual care).
Eligibility Criteria
Inclusion Criteria
- 21 and older
- English or spanish speaking
- Primarily responsible for administering own medications
- New prescription of one of 66 study medications on day of recruitment
- Has a personal mobile or land line phone
Exclusion Criteria
- Severe, uncorrectable vision
- Hearing or cognitive impairments
Data sourced from ClinicalTrials.gov (NCT02785458). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.